Design Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	15.09	22.56	21.2	26.5	298.57	2.38
Short-Term Investments	190.88	222.91	260.6	303.89	85.5	33.71
Cash & Short-Term Investments	205.97	245.48	281.8	330.39	384.06	36.09
Cash Growth	-18.93%	-12.89%	-14.71%	-13.98%	964.15%	46771.43%
Other Current Assets	3.06	2.56	2.79	4.73	1.37	0.14
Total Current Assets	209.03	248.04	284.58	335.12	385.44	36.23
Net Property, Plant & Equipment	2.74	3.63	4.63	5.56	5.12	0.07
Other Long-Term Assets	-	0.43	0.43	0.46	-	0.21
Total Assets	211.77	252.09	289.64	341.14	390.56	36.52
Accounts Payable	1.91	2.19	1.94	3.03	1.62	1.4
Accrued Expenses	9.26	6.28	7.68	7.75	3.66	0.93
Total Current Liabilities	11.17	8.46	9.62	10.78	5.28	2.33
Long-Term Leases	0.88	1.53	2.33	3.05	3.14	-
Other Long-Term Liabilities	-	-	-	-	-	0.15
Total Long-Term Liabilities	0.88	1.53	2.33	3.05	3.14	0.15
Total Liabilities	12.05	10	11.96	13.83	8.43	2.48
Common Stock	0.01	0.01	0	0.01	0.01	0
Additional Paid-in Capital	480.37	468.83	455.25	441.42	429.82	0.45
Accumulated Other Comprehensive Income	0.36	0.48	0.06	-3.36	-0.24	0.16
Retained Earnings	-281.01	-227.21	-177.63	-110.76	-47.46	-11.92
Total Common Shareholders' Equity	199.72	242.1	277.69	327.31	382.13	-11.32
Minority Interest	-	-	-	-	-	45.36
Shareholders' Equity	199.72	242.1	277.69	327.31	382.13	34.04
Total Liabilities & Equity	211.77	252.09	289.64	341.14	390.56	36.52
Total Debt	0.88	1.53	2.33	3.05	3.14	0
Net Cash (Debt)	205.09	243.94	279.46	327.34	380.92	36.09
Net Cash Growth	-15.93%	-12.71%	-14.63%	-14.07%	955.44%	-
Net Cash Per Share	3.61	4.31	4.99	5.88	8.29	2.29
Book Value	199.72	242.1	277.69	327.31	382.13	-11.32
Book Value Per Share	3.52	4.28	4.96	5.88	8.32	-0.72
Tangible Book Value	199.72	242.1	277.69	327.31	382.13	-11.32
Tangible Book Value Per Share	3.52	4.28	4.96	5.88	8.32	-0.72

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q